ProfileGDS4459 / ENSG00000150991
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 85% 87% 82% 90% 86% 87% 95% 80% 86% 89% 80% 81% 85% 90% 85% 88% 89% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 16.4985
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 26.6987
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 36.4682
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 46.9890
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 56.8186
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 66.987
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 78.2695
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 86.1780
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 96.8886
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 107.1189
GSM623474group B, liver allograft wedge biopsie placebo treatment 16.1580
GSM623475group B, liver allograft wedge biopsie placebo treatment 26.3681
GSM623476group B, liver allograft wedge biopsie placebo treatment 36.685
GSM623477group B, liver allograft wedge biopsie placebo treatment 47.1390
GSM623478group B, liver allograft wedge biopsie placebo treatment 56.7585
GSM623479group B, liver allograft wedge biopsie placebo treatment 66.8488
GSM623480group B, liver allograft wedge biopsie placebo treatment 77.0489